Aldevron

Great couple of days in Naples at the Advanced Cell and Gene Therapy Workshop.
It was a rewarding opportunity to engage with a highly motivated group of PhD students focused on advancing RNA and gene therapy.

A standout moment was Aldevron's Ilaria Chiarugi’s session with Abdelilah Mekhloufi from Integrated DNA Technologies, “In Vivo Gene Therapy: The Case of Baby KJ.” The discussion connected real-world application with core scientific principles and led to thoughtful questions and strong engagement from the audience.

Workshops like this play an important role in sharing knowledge, supporting early-career researchers, and continuing to build momentum across the RNA space.

Thank you to the organizers and everyone who participated.

This Friday, June 12, Aldevron's Ilaria Chiarugi will be part of a talk at the Advanced Cell and Gene Therapy Workshop in Naples.

Together with Abdelilah Mekhloufi from Integrated DNA Technologies, she will lead a session titled “In Vivo Gene Therapy: The Case of Baby KJ.” The talk will explore how real-world applications of gene therapy are shaping the path from research to clinical impact, bringing important scientific discussion directly to the next generation of researchers.

This workshop reflects a continued commitment to learning and leadership in RNA and gene therapy, with a focus on sharing knowledge in an academic setting where it can have lasting impact.
If you are attending, it will be a strong opportunity to engage with emerging science and connect with peers in the field.

Learn more about the event here: https://ald.bio/3StR0XI

Access to research‑grade plasmid DNA and gene editing tools, paired with consistent performance and a streamlined ordering experience, helps remove the pressures of balancing speed and quality. Instead of navigating delays or variability, researchers can stay focused on advancing their work with materials they trust.

With academic-focused pricing designed to support discovery environments, it becomes easier to keep projects moving forward without overextending limited resources.

Explore what’s available:

https://ald.bio/4o0p4GA

The energy carried through earlier today at ICGT in Paris, where our joint ALD / IDT / Cytiva workshop—Accelerating Personalized CRISPR Therapies—brought together strong engagement around what it takes to advance these programs from concept to clinic.

Great to see the collaboration across teams and hear how others in the field are tackling challenges around speed, control, and scalability in personalized approaches. Sessions like this continue to reinforce how important integrated expertise is as expectations for performance and precision evolve.

If you’re attending ICGT, there’s still time to connect onsite.

Today, we pause to remember.

Memorial Day is a time to honor the men and women who gave their lives in service to others. Their sacrifice continues to shape the freedoms and opportunities we have today.

We recognize the weight of this day and the families and communities who carry it with them.

In observance of Memorial Day, our U.S. offices are closed today (May 25th).

We are heading to ICGT 2026 next week, May 27th and 28th, in France.

We will be with our friends at Cytiva and Integrated DNA Technologies both at the booth and during our May 27th workshop: Accelerating Personalized CRISPR Therapies. Catch our very own Tim Traynor alongside Abdelilah Mekhloufi (Integrated DNA Technologies) and Martin Rabel (Cytiva).

Don't miss out and make sure to visit us at ICGT to talk all things cell and gene therapies. Learn more about the conference: https://ald.bio/4dWfBgb

If you are thinking about nonviral approaches for cell engineering, this one is worth adding to your calendar.

We are hosting a Lunch and Learn with Trince in Leiden starting at 8:45 am CET, focused on practical considerations across DNA, RNA, and delivery for gene editing workflows.

Lunch, discussion, and real-world perspectives included.

Learn more and register here:

https://ald.bio/4ujMSb7

Ordering is more seamless for our European customers and now even more capable.

You can now place Nanoplasmid orders, including gene synthesis, directly through our e‑commerce platform—bringing more of your workflow into a single, streamlined experience. From discovery to pre-clinical research, it’s another step toward simplifying how science moves forward.

👉 Check it out: https://ald.bio/4wH8PCq

Clinical trials are foundational to advancing new therapies and improving patient care.

On International Clinical Trials Day, we recognize the researchers, clinicians, and participants whose commitment helps translate scientific discovery into meaningful health outcomes.

The 14th Galenus Workshop is underway, bringing together experts focused on advancing mRNA science and delivery.

Work across process optimization, quality, and scalability continues to push the field forward as expectations for performance and precision grow.

Tomorrow, our very own Nicolò Sacchetti will present a poster titled:
“Impact of dsRNA on cellular viability and reduction of dsRNA in in vitro transcribed mRNA via enzymatic optimization and polishing.”

May 19 | 12:30–12:45

If you’re attending, this is an opportunity to explore how dsRNA mitigation strategies can influence mRNA quality and downstream outcomes.